Related Experiment Video
Updated: Nov 10, 2025
08:41
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
3.0K
EVALI: A Mimicker of COVID-19
Mitchell M Pitlick1, Daenielle K Lang1, Anne M Meehan2
1Department of Internal Medicine, Mayo Clinic, Rochester, MN.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes
|April 5, 2021
Summary
E-cigarette or vaping product use-associated lung injury (EVALI) mimics COVID-19 symptoms, potentially delaying diagnosis. This study highlights three cases where EVALI was diagnosed after initial COVID-19 suspicion.
Area of Science:
- Pulmonology
- Toxicology
- Infectious Disease Epidemiology
Background:
- E-cigarette or vaping product use-associated lung injury (EVALI) presents with respiratory symptoms similar to COVID-19.
- The ongoing COVID-19 pandemic creates diagnostic challenges due to overlapping clinical presentations.
Observation:
- Three hospitalized patients initially suspected of having COVID-19 were diagnosed with EVALI.
- Anchoring bias towards COVID-19 may impede timely EVALI diagnosis.
Findings:
- EVALI diagnosis requires consideration even in patients with COVID-19-like symptoms.
- Vaping-associated lung injury can be mistaken for viral pneumonia.
Implications:
- Clinicians should maintain a broad differential diagnosis for respiratory illness during the pandemic.
- Awareness of EVALI is crucial to prevent delayed or missed diagnoses in patients with a history of vaping.
- Public health messaging should address the risks of e-cigarette use and its potential to cause severe lung injury.
Keywords:
COVID-19, coronavirus disease 2019CRP, C-reactive proteinCT, computed tomographyEVALI, e-cigarette or vaping product use–associated lung injuryIV, intravenousPCR, polymerase chain reactionSARS-CoV-2, severe acute respiratory syndrome coronavirus 2More Related Videos
Related Concept Videos
01:13Nonconscious Mimicry
4.8K
Nonconscious mimicry occurs when individuals alter their mannerisms to match the behaviors and expressions of those nearby, without intention.
4.8K
01:13Controls in Experiments
14.3K
When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
14.3K
01:33Enzyme-Linked Immunosorbent Assay
15.7K
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
15.7K
00:57Viral Recombination
24.3K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.3K